4.7 Review

Pharmacogenetics of Lethal Opioid Overdose: Review of Current Evidence and Preliminary Results from a Pilot Study

Related references

Note: Only part of the references are listed.
Review Pharmacology & Pharmacy

Pharmacological data science perspective on fatal incidents of morphine treatment

Yazan Noufal et al.

Summary: Prescription of morphine for analgesia has been associated with drug-related deaths at an incidence rate of 0.3% to 4%. The pharmacological properties of morphine make it challenging to determine the causality between morphine administration and patient death, including its slow transfer in the body and the presence of an active metabolite with opioid effects. There is also no defined toxic dose or concentration of morphine. This article summarizes reported deaths related to morphine therapy and analyzes the stability of morphine and its metabolites in postmortem biological samples. It emphasizes the limited validity of inferring the administered dose from postmortem blood concentrations and highlights the need for collaborative assessment among medical experts.

PHARMACOLOGY & THERAPEUTICS (2023)

Article Multidisciplinary Sciences

Positive associations between cannabis and alcohol use polygenic risk scores and phenotypic opioid misuse among African-Americans

Jill A. Rabinowitz et al.

Summary: This study examined the association between polygenic risk scores (PRS) for lifetime cannabis and alcohol use and the misuse of opioids among an urban, African-American sample. The findings suggest that higher PRS for lifetime cannabis use, heavy drinking, and alcohol consumption are associated with an increased risk for opioid misuse. Additionally, there are significant sex differences in these associations.

PLOS ONE (2022)

Article Medicine, Research & Experimental

Reviewing pharmacogenetics to advance precision medicine for opioids

Leen Magarbeh et al.

Summary: Pharmacogenetic evidence supports the association between CYP2D6 genetic variants and opioid metabolism, with CPIC guidelines recommending avoidance of tramadol in poor and ultrarapid metabolizers. Although OPRM1 gene suggests increased morphine dosing requirements postoperatively, the clinical relevance remains limited.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Article Pharmacology & Pharmacy

Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy

Kristine R. Crews et al.

Summary: Opioids are commonly used for the treatment of acute and chronic pain, and the clinical effects and adverse events are associated with genes such as CYP2D6, OPRM1, and COMT. While there is extensive research on the association between CYP2D6 and codeine/tramadol, data for hydrocodone, oxycodone, methadone, OPRM1, and COMT are more limited.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)

Article Medicine, Legal

Brain/blood ratios of methadone and ABCB1 polymorphisms in methadone-related deaths

S. Iwersen-Bergmann et al.

Summary: The study found that polymorphisms in the ABCB1 gene, specifically rs1045642, may influence methadone concentrations in the brain and its effects, potentially impacting methadone toxicity.

INTERNATIONAL JOURNAL OF LEGAL MEDICINE (2021)

Review Environmental Sciences

Pharmacogenetics and Forensic Toxicology: A New Step towards a Multidisciplinary Approach

Nunzio Di Nunno et al.

Summary: Pharmacogenetics is a research field that analyzes the individual behavior of DNA genes after drug administration. Recent advancements in genome sequencing and molecular genetics have allowed for the implementation of pharmacogenetic research, which is crucial for clarifying toxicological data in post-mortem examinations and determining causes and modes of death. Several studies emphasize the importance of pharmacogenetics in drug-related deaths, especially in cases where drug abuse does not lead to overdoses.

TOXICS (2021)

Article Genetics & Heredity

Oxycodone findings and CYP2D6 function in postmortem cases

Gerd Jakobsson et al.

Summary: This study investigates the impact of CYP2D6 phenotype on oxycodone concentrations in postmortem cases, finding that poor and intermediate metabolizers have higher concentrations compared to extensive and ultra-rapid metabolizers. The distribution of CYP2D6 phenotypes was similar among different causes of death, indicating no overrepresentation of a particular phenotype in any cause of death group. Additionally, the ratio of oxymorphone to oxycodone is dependent on CYP2D6 activity, with a lower ratio indicating acute intake and potentially serving as a sensitive marker for distinguishing oxycodone intoxications from other causes of death.

FORENSIC SCIENCE INTERNATIONAL-GENETICS (2021)

Article Clinical Neurology

Relative addictive potential of opioid analgesic agents

Nicholas J. Connors et al.

Summary: Opioid overdoses and deaths remain a problem in the USA, with research focusing on the role of pharmacogenetic factors in opioid addiction. Different opioid analgesic agents have varying levels of addictive potential, and healthcare providers should consider these risks when prescribing opioids, opting for those with lower addictive potential.

PAIN MANAGEMENT (2021)

Review Biotechnology & Applied Microbiology

Fentanyl overdoses and pharmacogenetics

Glenn S. Gerhard et al.

PHARMACOGENETICS AND GENOMICS (2020)

Review Genetics & Heredity

A Review of the Important Role of CYP2D6 in Pharmacogenomics

Christopher Taylor et al.

GENES (2020)

Article Biochemistry & Molecular Biology

A pathway-driven predictive model of tramadol pharmacogenetics

Frank R. Wendt et al.

EUROPEAN JOURNAL OF HUMAN GENETICS (2019)

Article Medicine, Legal

Supervised Classification of CYP2D6 Genotype and Metabolizer Phenotype With Postmortem Tramadol-Exposed Finns

Frank R. Wendt et al.

AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY (2019)

Article Psychology, Clinical

Pharmacogenetic analysis of opioid dependence treatment dose and dropout rate

Richard C. Crist et al.

AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2018)

Review Neurosciences

Untangling the complexity of opioid receptor function

Rita J. Valentino et al.

NEUROPSYCHOPHARMACOLOGY (2018)

Review Medical Laboratory Technology

Pharmacogenetics of Opioid Use and Implications for Pain Management

Robert D. Nerenz et al.

JOURNAL OF APPLIED LABORATORY MEDICINE (2018)

Article Chemistry, Analytical

Tell-Tale SNPs: The Role of CYP2B6 in Methadone Fatalities

Taha Ahmad et al.

JOURNAL OF ANALYTICAL TOXICOLOGY (2017)

Review Pharmacology & Pharmacy

Review of Opioid Pharmacogenetics and Considerations for Pain Management

Aniwaa Owusu Obeng et al.

PHARMACOTHERAPY (2017)

Article Medicine, Legal

Sequencing CYP2D6 for the detection of poor-metabolizers in post-mortem blood samples with tramadol

Suzana Fonseca et al.

FORENSIC SCIENCE INTERNATIONAL (2016)

Article Anesthesiology

Methadone Pharmacogenetics

Evan D. Kharasch et al.

ANESTHESIOLOGY (2015)

Article Pharmacology & Pharmacy

Addressing phenoconversion: the Achilles' heel of personalized medicine

Rashmi R. Shah et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)

Article Pharmacology & Pharmacy

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing

K. A. Birdwell et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)

Article Medicine, Legal

Codeine-related deaths: The role of pharmacogenetics and drug interactions

Jessica Lama et al.

FORENSIC SCIENCE INTERNATIONAL (2014)

Article Chemistry, Analytical

Fatal Methadone Toxicity: Potential Role of CYP3A4 Genetic Polymorphism

Lauren L. Richards-Waugh et al.

JOURNAL OF ANALYTICAL TOXICOLOGY (2014)

Article Biochemistry & Molecular Biology

CYP2B6 and OPRM1 gene variations predict methadone-related deaths

Hannah Bunten et al.

ADDICTION BIOLOGY (2011)

Article Pharmacology & Pharmacy

OPRM1 and CYP2B6 Gene Variants as Risk Factors in Methadone-Related Deaths

H. Bunten et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)

Article Substance Abuse

Effect of Cocaine Use on Methadone Pharmacokinetics in Humans

Elinore F. McCance-Katz et al.

AMERICAN JOURNAL ON ADDICTIONS (2010)

Article Biochemistry & Molecular Biology

ABCB1 (MDR1) genetic variants are associated with methadone doses required for effective treatment of heroin dependence

Orna Levran et al.

HUMAN MOLECULAR GENETICS (2008)